Michihiro Kamijima Selected Research

Trichloroethylene (Trichloroethene)

10/2022	Increased serum anti-CYP2E1 IgG autoantibody levels may be involved in the pathogenesis of occupational trichloroethylene hypersensitivity syndrome: a case-control study.
12/2020	Increased risk of occupational trichloroethylene hypersensitivity syndrome at exposure levels higher than 15 mg/L of urinary trichloroacetic acid, regardless of whether the patients had the HLA-B*13:01 allele.
1/2020	Trichloroethylene and trichloroethanol induce skin sensitization with focal hepatic necrosis in guinea pigs.
7/2018	Exposure reconstruction of trichloroethylene among patients with occupational trichloroethylene hypersensitivity syndrome.
12/2013	Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
1/2013	Sex differences in metabolism of trichloroethylene and trichloroethanol in guinea pigs.
1/2012	Upregulation of calprotectin and downregulation of retinol binding protein in the serum of workers with trichloroethylene-induced hypersensitivity dermatitis.
11/2010	Differential response to trichloroethylene-induced hepatosteatosis in wild-type and PPARalpha-humanized mice.
8/2010	Occupational trichloroethylene hypersensitivity syndrome with human herpesvirus-6 and cytomegalovirus reactivation.
1/2008	Characterization of liver injury associated with hypersensitive skin reactions induced by trichloroethylene in the guinea pig maximization test.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michihiro Kamijima Research Topics

Disease

10	Hepatitis 10/2022 - 03/2002
10	Hypersensitivity (Allergy) 10/2022 - 11/2006
8	Inflammation (Inflammations) 01/2020 - 05/2007
6	Dermatitis 01/2020 - 01/2003
4	Leukemia 01/2021 - 12/2012
4	Exanthema (Rash) 12/2013 - 11/2006
3	Sick Building Syndrome 11/2021 - 08/2016
3	Neoplasms (Cancer) 12/2012 - 05/2007
3	Drug Hypersensitivity (Drug Allergy) 01/2008 - 11/2006
2	Birth Weight (Birth Weights) 01/2022 - 01/2020
2	Body Weight (Weight, Body) 01/2022 - 08/2007
2	Hepatomegaly 11/2021 - 01/2003
2	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021 - 02/2019
2	Necrosis 01/2020 - 11/2010
2	Malignant Mesothelioma 07/2015 - 01/2014
2	Lung Neoplasms (Lung Cancer) 07/2015 - 01/2014
2	Congenital Abnormalities (Deformity) 09/2014 - 10/2013
2	Mesothelioma 01/2014 - 01/2014
2	Carcinogenesis 01/2014 - 05/2007
2	Neurogenic Inflammation 12/2011 - 03/2011
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2003 - 03/2002
1	Asthma (Bronchial Asthma) 01/2022
1	Respiratory Sounds (Crackle) 01/2022
1	Weight Gain 01/2022
1	Neurodevelopmental Disorders 11/2021
1	Postpartum Depression (Post-Natal Depression) 07/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2020
1	Threatened Abortion 04/2019
1	Venous Thromboembolism 04/2019
1	Infections 01/2019
1	Stillbirth 01/2019
1	Asbestosis 07/2015
1	Hydrothorax 07/2015
1	Aneuploidy (Aneuploid) 11/2014
1	Hypertriglyceridemia 02/2014

Drug/Important Bio-Agent (IBA)

15	Trichloroethylene (Trichloroethene)IBA 10/2022 - 03/2002
4	PPAR alphaIBA 11/2021 - 08/2006
4	Pharmaceutical PreparationsIBA 12/2013 - 11/2006
3	CadmiumIBA 01/2022 - 02/2019
3	LipidsIBA 11/2021 - 11/2010
3	Volatile Organic CompoundsIBA 11/2021 - 01/2021
3	2-ethylhexanolIBA 11/2021 - 08/2016
3	EndocannabinoidsIBA 02/2020 - 02/2014
3	EnzymesIBA 02/2020 - 01/2014
3	InsecticidesIBA 01/2020 - 10/2013
3	AsbestosIBA 07/2015 - 01/2014
3	SolventsIBA 12/2013 - 04/2007
2	SeleniumIBA 01/2022 - 06/2007
2	ORALIT (ORS)IBA 01/2022 - 01/2019
2	Diethylhexyl Phthalate (DEHP)IBA 01/2021 - 05/2007
2	phthalic acid (phthalate)IBA 01/2021 - 01/2019
2	Trichloroacetic AcidIBA 12/2020 - 11/2010
2	OrganophosphatesIBA 02/2020 - 02/2014
2	Pyrethrins (Pyrethroids)FDA Link 01/2020 - 12/2012
2	PlasticizersIBA 01/2019 - 05/2007
2	PesticidesIBA 08/2015 - 12/2012
2	FenitrothionIBA 09/2014 - 02/2014
2	Air Pollutants (Pollutants, Air)IBA 04/2014 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 12/2013 - 01/2012
2	Nerve Growth Factor (NGF)IBA 12/2011 - 03/2011
2	Nerve Growth Factors (Neurotrophins)IBA 12/2011 - 03/2011
2	TachykininsIBA 12/2011 - 03/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2011 - 08/2006
1	Immunoglobulin G (IgG)IBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	CholesterolIBA 01/2022
1	KeroseneIBA 01/2022
1	ManganeseIBA 01/2022
1	MercuryIBA 01/2022
1	perfluorooctanoic acidIBA 01/2021
1	Dibutyl Phthalate (Butyl Phthalate)IBA 01/2021
1	mono-benzyl phthalateIBA 01/2021
1	bisphenol AIBA 01/2021
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 12/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	2,2,2-trichloroethanolIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	methylallyl trisulfide (MATS)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2019
1	Chemokine CCL3IBA 07/2015
1	dichlorobis(azomycin)platinum IIIBA 11/2014
1	CannabinoidsIBA 02/2014
1	NitrogenIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	EndonucleasesIBA 01/2014
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2014
1	8-nitroguanineIBA 01/2014
1	Serpentine Asbestos (Chrysotile)IBA 01/2014

Therapy/Procedure

2	Cesarean Section (Caesarean Section) 04/2019 - 01/2019
1	Obstetrical Anesthesia 07/2021
1	Epidural Analgesia 07/2021
1	Analgesia 07/2021
1	Anesthesia 07/2021